Evolent Health (EVH) Debt to Equity (2019 - 2026)

Evolent Health's Debt to Equity history runs 8 years deep, the most recent figure standing at $2.46 for Q1 2026.

• In Q1 2026, Debt to Equity rose 180.41% year-over-year to $2.46; the TTM figure through Mar 2026 stood at $2.46 (up 180.41% YoY), while the FY2025 annual figure was $2.34, up 253.56% from the prior year.
• Debt to Equity was $2.46 for Q1 2026 at Evolent Health, up from $2.34 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $2.46 in Q1 2026 to a low of $0.46 in Q2 2022.
• Historically, Debt to Equity has averaged $0.84 across 5 years, with a median of $0.57 in 2024.
• The sharpest annual moves came in 2024 and 2025: Debt to Equity fell 1.87% in 2024, then soared 253.56% in 2025.
• A 5-year view of Debt to Equity shows it stood at $0.48 in 2022, then increased by 16.37% to $0.56 in 2023, then increased by 18.23% to $0.66 in 2024, then jumped by 253.56% to $2.34 in 2025, then climbed by 5.06% to $2.46 in 2026.
• The last three Debt to Equity figures came in at $2.46 (Q1 2026), $2.34 (Q4 2025), and $1.26 (Q3 2025), per Business Quant data.